SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
SEC Accession No. 0001193125-24-036603
Filing Date
2024-02-14
Accepted
2024-02-14 17:19:30
Documents
1
Effectiveness Date
2024-02-14

Document Format Files

Seq Description Document Type Size
1 S-8 POS d791807ds8pos.htm S-8 POS 17189
  Complete submission text file 0001193125-24-036603.txt   18352
Mailing Address 201 ELLIOTT AVE. W SUITE 260 SEATTLE WA 98119
Business Address 201 ELLIOTT AVE. W SUITE 260 SEATTLE WA 98119 206-568-1466
IMPEL PHARMACEUTICALS INC (Filer) CIK: 0001445499 (see all company filings)

IRS No.: 263058238 | State of Incorp.: DE | Fiscal Year End: 0426
Type: S-8 POS | Act: 33 | File No.: 333-263959 | Film No.: 24640629
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)